Developing models to understand infectious diseases.
Official title: Pre-Clinical Models of Infectious Diseases
Funded at Saint Louis University · NIH-11197693 · Data updated 2026-11-12
This study is working on creating models that mimic infectious diseases to help researchers find better treatments, which could lead to new options for patients dealing with infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Saint Louis University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | July 15, 2024 |
| Project end | July 14, 2031 |
| Funding year | 2024 |
| Award (this year) | $2,500 |
| NIH project number | 75N93024D00019-0-759302400001-1 |
| Project ID | NIH-11197693 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk of infectious diseases or those who have conditions that could be addressed by new medical countermeasures.
✕Less likely to help
Patients with non-infectious diseases or those who are not at risk for infectious diseases may not receive any benefit from this research.
What this research studies
This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and potential treatments. By using these models, researchers aim to evaluate the effectiveness of medical countermeasures and develop new strategies for combating infections. Patients may benefit from advancements in treatment options that arise from the insights gained through these models. The research employs a systematic approach to modeling various infectious diseases, which could lead to significant improvements in patient care.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments and preventive measures for infectious diseases.
How similar studies have gone: Other research has shown success in using pre-clinical models to advance our understanding of infectious diseases and develop effective treatments.
Where this research is happening
-
Saint Louis University
Saint Louis, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Selective Targeting of Nurr1 for Alzheimer’s Disease
A small study tests new brain-targeted compounds to help people with Alzheimer’s by reducing inflammation and protecting brain cells.
-
Understanding how TDP-43 clumps cause brain cell damage in dementia
A research team is studying how clumps of TDP-43 protein mess with brain cell functions in Alzheimer’s and related dementias, with the goal of identifying what goes wrong and where.
-
Encephalitogenic stem-like T cells in MS and its disease models
This grant explores a specific type of brain-accumulating T cell linked to multiple sclerosis and tests new analytical tools to understand them better.
-
Endothelial dysfunction in Alzheimer’s disease: a data-driven model for diagnosis and prognosis
This research explores brain blood vessel problems in people with Alzheimer’s to find new biomarkers that could help diagnose and predict progression.
-
How alcohol may damage the brain’s protective barrier and how to stop it
Researchers are studying how heavy drinking could weaken the brain’s shield by changing a signaling system called LPA in blood vessels of the brain, and whether blocking parts of this system could help.
-
A brain immune-cell receptor (GPR56) and its link to Alzheimer's
Testing whether changing activity of a microglial receptor called GPR56 can reduce Alzheimer's brain plaques and related damage in people with Alzheimer's disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.